Tobramycin Solution
Product Images NDC 60687-731

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 60687-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A (Figure A)

Figure A (Figure A)
An instructional diagram showing components and accessories for a respiratory inhalation solution. Labeled parts include an air compressor, nebulizer cup, inspiratory valve cap, ampule, mouthpiece, tubing, and clean paper or cloth towels, arranged on a flat surface.*
FDA Label Image

Figure B (Figure B)

Figure B (Figure B)
An illustration showing a Tobramycin solution vial for respiratory inhalation with an arrow pointing to the area on the vial where the expiration date is printed. The vial is depicted horizontally with a cap on the right side.*
FDA Label Image

Figure C (Figure C)

Figure C (Figure C)
An instructional diagram showing the assembly of a nebulizer device for respiratory inhalation. Components labeled include the Nebulizer Top, Nebulizer Cup, Mouthpiece, Inspiratory Valve Cap, and Tubing, with hands demonstrating how to place the Nebulizer Top onto the cup.*
FDA Label Image

Figure D (Figure D)

Figure D (Figure D)
An instructional illustration showing the assembly of a nebulizer for respiratory inhalation. The diagram depicts a hand inserting the nebulizer insert into the nebulizer cup, with labeled parts including the top, nebulizer insert, and nebulizer cup.*
FDA Label Image

Figure E (Figure E)

Figure E (Figure E)
An instructional illustration showing a nebulizer cup and its removable top placed on clean paper or cloth towels. The diagram labels the parts of the nebulizer for assembly or cleaning guidance.*
FDA Label Image

Figure F (Figure F)

Figure F (Figure F)
An instructional illustration showing a hand inserting or removing a single dose ampule into a Pulmo-Aide nebulizer device. The nebulizer is depicted as a box-like respiratory device used for inhalation therapy.*
FDA Label Image

Figure G (Figure G)

Figure G (Figure G)
Illustration showing a hand unplugging a two-prong electrical plug from a wall outlet, with an arrow indicating the direction of removal.*
FDA Label Image

Figure H (Figure H)

Figure H (Figure H)
An instructional line drawing showing hands holding a vial labeled 'STERILE' and 'For oral inhalation only.' An arrow indicates rotating or pulling a top section, with a label pointing to the vial's bottom tab. The image demonstrates how to open or prepare the vial for respiratory inhalation use.*
FDA Label Image

Figure I (Figure I)

Figure I (Figure I)
An instructional line drawing showing a hand holding a Tobramycin inhalation solution ampule above a nebulizer chamber, illustrating the step of adding the solution dropwise into the nebulizer's medicine cup for respiratory administration.*
FDA Label Image

Figure J (Figure J)

Figure J (Figure J)
An instructional diagram showing components of a nebulizer for inhalation solution use. It depicts the nebulizer top with a semi-circle and stem, the nebulizer cup, and the nebulizer outlet, illustrating assembly or parts identification for the nebulizer device.*
FDA Label Image

Figure K (Figure K)

Figure K (Figure K)
An instructional diagram illustrating the assembly of a nebulizer device. It shows the mouthpiece that attaches to the nebulizer outlet on the nebulizer cup, highlighting key parts labeled as Mouthpiece, Nebulizer Outlet, and Nebulizer Cup.*
FDA Label Image

Figure L (Figure L)

Figure L (Figure L)
An instructional diagram showing the removal or placement of the inspiratory valve cap on a respiratory inhalation device. The device has a mouthpiece and a handle, with arrows indicating the direction to place or remove the valve cap from the top opening.*
FDA Label Image

Figure M (Figure M)

Figure M (Figure M)
An instructional diagram showing assembly of a respiratory inhalation device for Tobramycin solution. The image depicts the connection of a mouthpiece with an air intake labeled, attached to the main body, along with positioning of tubing or a connector below, indicated by upward arrows guiding assembly.*
FDA Label Image

Figure N (Figure N)

Figure N (Figure N)
An instructional illustration showing a hand inserting or adjusting a key or tab on a rectangular device labeled 'Pulmo-Aide', likely a medical or respiratory equipment component related to inhalation therapy.*
FDA Label Image

Figure O (Figure O)

Figure O (Figure O)
An instructional illustration showing a respiratory inhalation device in use, releasing a cloud of aerosolized solution from the mouthpiece.*
FDA Label Image

Figure P (Figure P)

Figure P (Figure P)
An instructional diagram showing a side view of a person using a respiratory inhalation device with a nose clip applied to the nose. The illustration highlights the correct placement of the nose clip during inhalation therapy.*
FDA Label Image

Structural Formula (Structure 01)

Structural Formula (Structure 01)
Chemical structure of Tobramycin, showing its molecular arrangement with multiple hydroxyl (OH) groups and amino (NH2) groups in a sugar-like ring formation.*
FDA Label Image

300 mg/5 mL Tobramycin Inhalation Solution Carton (Tobramycin Inhalation Solution Carton)

300 mg/5 mL Tobramycin Inhalation Solution Carton (Tobramycin Inhalation Solution Carton)
Tobramycin Inhalation Solution USP 300 mg/5 mL label showing packaging for 30 unit-dose 5 mL ampules in foil pouches. The label indicates it is for inhalation only by nebulizer, contains no preservatives, and requires refrigeration. Distributed by American Health Packaging, with instructions for pharmacist dispensing and storage information.*
FDA Label Image

300 mg/5 mL Tobramycin Inhalation Solution Foil Pouch (Tobramycin Inhalation Solution Foil Pouch)

300 mg/5 mL Tobramycin Inhalation Solution Foil Pouch (Tobramycin Inhalation Solution Foil Pouch)
Label for Tobramycin Inhalation Solution USP 300 mg/5 mL by American Health Packaging. The label includes storage instructions to refrigerate, usage for inhalation by nebulizer only, and notes that it contains no preservatives. It is provided as single-dose ampules, with dosage and storage details included.*
FDA Label Image

Figure 2: Absolute Change From Baseline In Log10 Cfus (Figure 2)

Figure 2: Absolute Change From Baseline In Log10 Cfus (Figure 2)
A line graph titled 'Figure 2: Absolute Change From Baseline in Log10 CFUs' showing average change in Log10 CFUs over 24 weeks. The x-axis represents weeks with marked intervals where subjects were 'on drug.' The y-axis shows average change of Log10 CFUs from -2.2 to 0.6. Four lines depict results for Study 1 and Study 2 with Tobramycin and Placebo groups, illustrating differences in microbial change over time between placebo and Tobramycin treatments.*
FDA Label Image

Figure 1: Relative Change From Baseline In Fev1 % Predicted (Spl Tobramycin Figure)

Figure 1: Relative Change From Baseline In Fev1 % Predicted (Spl Tobramycin Figure)
A line graph titled 'Relative Change From Baseline in FEV1% Predicted' showing average relative change in FEV1% predicted over 24 weeks. Four groups are represented: Tobramycin Study 1 (n=109), Tobramycin Study 2 (n=149), Placebo Study 1 (n=114), and Placebo Study 2 (n=148). The x-axis is labeled 'Week' from 0 to 24 with periods marked 'on drug.' The y-axis shows average relative change from -4 to 16 percent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.